Biopharmaceutical Research & Development (R&D) aims at finding new modalities to diagnose, prevent, and treat human diseases. Prototypes of innovative approaches are tested in biological systems of increasing size, complexity, and relevance. Active Drug Ingredient (API) is a substance used to diagnose, treat, reduce, cure, or prevent disease. Medicines can be solid (pill, capsule), semi-solid (ointment, cream), liquid, suspension, emulsion, etc., for internal or local use. It is given in some drug or drug forms such as Pharmaceutical products can be thought of as pharmaceutical products that release and deliver drugs to the site of action, cause desired medical results, and are also specifically designed to meet the patient's needs such as palatability, convenience, and safety. Health authorities around the world play a key role in this process. During the clinical test phase, together with the biopharmaceutical companies, they surveil and ensure the scientifically sound and safe conduct of clinical trials. In a second step, health authorities review the entire data set that has been generated during both the exploratory and the confirmatory phases. If, based on these data, they come to conclude that the benefits conferred to the patients outweigh the risks, authorization to market the drug in the respective country is conferred. In order to get reimbursed, approved new drugs need to undergo an economic review process. There the decision is made if the new drug confers enough clinical benefits to justify its price. The drug approval process and the economic evaluation/reimbursement process are two distinct processes carried out by different institutions. Although R&D leverages a number of academic disciplines like epidemiology, genetics, biology, chemistry, bioinformatics, pharmacology, toxicology, pharmacy, and medicine, it is not primarily an academic discipline and cannot be studied in one program at a university. It is difficult to find coherent overarching information on concepts generally applicable to the industry beyond individual company processes. Thus, this book chapter attempts to bridge this gap and provide an overview and concepts and reliable details which apply across the industry and are valuable for everyone working in or with the biopharmaceutical industry.